Deciphering the sinus tachycardias

Clinical Cardiology

Volumn 28, Issue 6, 2005, Pages 267-276

  Yusuf, Shamil ^a   Camm, A John ^a,b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b Department of Clinical Cardiology ^*

Author keywords

Inappropriate sinus tachycardia; Postural orthostatic tachycardia syndrome; Sinus node reentry tachycardia; Sinus tachycardia

Indexed keywords

ADENOSINE; ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMIODARONE; ANTIARRHYTHMIC AGENT; BARBITAL; BARBITURIC ACID DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CARBIMAZOLE; CLONIDINE; CYCLIC AMP; DIGOXIN; DILTIAZEM; DISOPYRAMIDE; ERGOTAMINE; ERYTHROPOIETIN; FLECAINIDE; FLUDROCORTISONE; ISOPRENALINE; IVABRADINE; METHYLPHENIDATE; METHYLXANTHINE; MIDODRINE; MINERALOCORTICOID; NORADRENALIN; NORADRENALIN TRANSPORTER; OCTREOTIDE; PHETHARBITAL; POTASSIUM CHANNEL; PROPYLTHIOURACIL; SEROTONIN UPTAKE INHIBITOR; SOTALOL; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VENLAFAXINE; VERAPAMIL;

ACUTE HEART INFARCTION; ANXIETY DISORDER; BRADYCARDIA; CATHETER ABLATION; CELL MEMBRANE PERMEABILITY; CLINICAL FEATURE; COLD LIMB; COMPRESSION THERAPY; CONGESTIVE HEART FAILURE; CONSULTATION; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; ELECTROCARDIOGRAPHY; EXERCISE; FATIGUE; FLUID THERAPY; FRUSTRATION; GENERAL PRACTITIONER; HEART ATRIOVENTRICULAR NODE; HEART ATRIUM FLUTTER; HUMAN; HYPERSENSITIVITY REACTION; IMPOTENCE; INAPPROPRIATE SINUS TACHYCARDIA; POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME; PROGNOSIS; RECURRENT DISEASE; REENTRY TACHYCARDIA; REVIEW; SIDE EFFECT; SINUS TACHYCARDIA; SODIUM RESTRICTION; VISUAL DISORDER; WEIGHT LIFTING;

EID: 20444427538     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960280603     Document Type: Review

References (85)

1. Levine HJ: Rest heart rate and life expectancy. J Am Coll Cardiol 1997;30: 1104-1106
2. Habib G: Is heart rate a risk factor in the general population? Dialogues Cardiovasc Med 2001;6:25-31
3. Criteria Committee of the New York Heart Association, 5th Ed. New York: New York Heart Association (1953)
4. Spodick D: Normal sinus heart rate: Sinus tachycardia and sinus bradycardia redefined. Am Heart J 1992;124:1119-1121
5. Krahn AD, Yee R, Klein GJ, Morillo C: Inappropriate sinus tachycardia: Evaluation and therapy. J Cardiovasc Electrophysiol 1995;6:1124-1128
6. Cossu SF, Steinberg JS: Supraventricular tachyarrhythmias involving the sinus node: Clinical and electrophysiologic characteristics. Prog Cardiovasc Dis 1998;41:51-63
7. Low PA, Opfer-Gehrking TL, Textor SC, et al.: Postural tachycardia syndrome (POTS). Neurology 1995;45:S19-25
8. Low P, Schondorf R, Novak V: Postural Tachycardia Syndromes. Clinical Autonomic Disorders: Evaluation and Management, 2nd Ed., p. 681-697, 1997
9. Anderson RH, Ho SY: The architecture of the sinus node, the atrioventricular conduction axis, and the internodal atrial myocardium. J Cardiovasc Electrophysiol 1998;9:1233-1248
10. Ogawa S, Dreifus L, Osmick M: Induction of sinus node reentry: Its relation to inhomogeneous atrial conduction. J Electrophysiol 1978;11:109-116
11. DiFrancesco D: Pacemaker mechanisms in cardiac tissue. Ann Rev Physiol 1993;55:455-472
12. DiFrancesco D: Characterization of single pacemaker channels in cardiac sino-atrial node cells. Nature 1986;324:470-473
13. Morillo CA, Klein GJ, Thakur RK, Li H, Zardini M, Yee R: Mechanism of "inappropriate" sinus tachycardia. Role of sympathovagal balance. Circulation 1994;90:873-877
14. Bauernfiend R, Amat-y-Leon F, Dhingra R, Kehoe R, Wyndham C, Rosen K: Chronic non-paroxysmal sinus tachycardia in otherwise healthy persons. Ann Intern Med 1979;91:701-710
15. Farquhar WB, Taylor JA, Darling SE, Chase KP, Freeman R: Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation 2000;102:3086-3091
16. Shannon JR, Flattem NL, Jordan J, Jacob G, Black BK, Biaggioni I, Blakely RD, Robertson D: Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000;342:541-549
17. Singer W, Shen WK, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Low PA: Evidence of an intrinsic sinus node abnormality in patients with postural tachycardia syndrome. Mayo Clin Proc 2002;77:246-252
18. Jacob G, Costa F, Shannon JR, Robertson RM, Wathen M, Stein M, Biaggioni I, Ertl A, Black B, Robertson D: The neuropathic postural tachycardia syndrome. N Engl J Med 2000;343:1008-1014
19. Stewart JM: Pooling in chronic orthostatic intolerance: Arterial vasoconstrictive but not venous compliance defects. Circulation 2002;105:2274-2281
20. Freeman R, Lirofonis V, Farquhar WB, Risk M: Limb venous compliance in patients with idiopathic orthostatic intolerance and postural tachycardia. J Appl Physiol 2002;93:636-644
21. Schondorf R, Low PA: Idiopathic postural orthostatic tachycardia syndrome: An attenuated form of acute pandysautonomia? Neurology 1993;43:132-137
22. Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA: Postural tachycardia syndrome: Clinical features and follow-up study. Mayo Clin Proc 1999; 74:1106-1110
23. Stewart JM, Weldon A: The relation between lower limb pooling and blood flow during orthostasis in the postural orthostatic tachycardia syndrome of adolescents. J Pediatr 2001;138:512-519
24. Fouad FM, Tadena-Thome L, Bravo EL, Tarazi RC: Idiopathic hypovolemia. Ann Intern Med 1986;104:298-303
25. Streeten D: Orthostatic intolerance. Am J Med Sci 1999;317:78-87
26. Hoeldtke RD, Davis KM, Joseph J, Gonzales R, Panidis IP, Friedman AC: Hemodynamic effects of octreotide in patients with autonomic neuropathy. Circulation 1991;84:168-176
27. Tani H, Singer W, McPhee BR, Opfer-Gehrking TL, Haruma K, Kajiyama G, Low PA: Splanchnic-mesenteric capacitance bed in the postural tachycardia syndrome (POTS). Auton Neurosci 2000;86:107-113
28. Hoeldtke RD, Streeten DH: Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993;329:611-615
29. Stewart JM: Microvascular filtration is increased in postural tachycardia syndrome. Circulation 2003;107:2816-2822
30. Vernino S, Low PA, Fealey RD, Stewart JD, Farrugia G, Lennon VA: Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000;343:847-855
31. Boineau JP, Canavan TE, Schuessler RB, Cain ME, Corr PB, Cox JL: Demonstration of a widely distributed atrial pacemaker complex in the human heart. Circulation 1988;77:1221-1237
32. Lee RJ, Kaiman JM, Fitzpatrick AP, Epstein LM, Fisher WG, Olgin JE, Lesh MD, Scheinman MM: Radiofrequency catheter modification of the sinus node for "inappropriate" sinus tachycardia. Circulation 1995;92:2919-2928
33. Hoeldtke RD, Dworkin GE, Caspar SR, Israel BC: Sympathotonic orthostatic hypotension: A report of four cases. Neurology 1989;39:34-40
34. Grubb BP, Kosinski DJ, Boehm K, Kip K: The postural orthostatic tachycardia syndrome: A neurocardiogenic variant identified during head-up tilt table testing. Pacing Clin Electrophysiol 1997;20:2205-2212
35. Olgin J, Zipes D: Specific Arrhythmias: Diagnosis and Treatment. In Heart Diseases. A Textbook of Cardiovascular Medicine, pp. 815-889 (Eds. Braunwald E, Zipes D, Libby P). Philadelphia: WB Saunders, 2001
36. Grubb BP, Kanjwal MY, Kosinski DJ: Review: The postural orthostatic tachycardia syndrome: Current concepts in pathophysiology diagnosis and management. J Intervent Cardiol Electrophysiol 2001;5:9-16
37. Lorenzo F, Hargraeves J, Kakkan V: Possible relationship between chronic fatigue and postural tachycardia syndromes. Clin Autonom Res 1996;6: 263-264
38. Gomes J, Hariman R, Kang P, Chowdry I: Sustained symptomatic sinus node reentrant tachycardia: Incidence, clinical significance, electrophysiologic observations and the effects of antiarrhyrhmic agents. J Am Coll Cardiol 1985;5:45-57
39. Streeten DH, Anderson GH Jr, Richardson R, Thomas FD: Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: Evidence for excessive venous pooling. J Lab Clin Med 1988;111:326-335
40. Low PA, Caskey PE, Tuck RR, Fealey RD, Dyck PJ: Quantitative sudomotor axon reflex test in normal and neuropathic subjects. Ann Neurol 1983;14: 573-580
41. Hoeldtke RD, Davis KM: The orthostatic tachycardia syndrome: Evaluation of autonomic function and treatment with octreotide and ergot alkaloids. J Clin Endocrinol Metab 1991;73:132-139
42. Ten Harkel AD, Van Lieshout JJ, Wieling W: Treatment of orthostatic hypotension with sleeping in the head-up tilt position, alone and in combination with fludrocortisone. J Intern Med 1992;232:139-145
43. van Lieshout JJ, ten Harkel AD, Wieling W: Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Anton Res 2000;10:35-42
44. van Lieshout JJ, ten Harkel AD, Wieling W: Physical manoeuvres for combating orthostatic dizziness in autonomic failure. Lancet 1992;339:897-898
45. Chierichetti SM, Moise G, Galeone M, Fiorella G, Lazzari R: Beta-blockers and psychic stress: A double-blind, placebo-controlled study of bopindolol vs. lorazepam and butalbital in surgical patients. Int J Clin Pharmacol Ther Toxicol 1985;23:510-514
46. Fogari R, Zoppi A, Corradi L, Pasotti C, Malamani GD, Gradnik R, Bokor D, Gala C: Comparison of bisoprolol and diazepam in the treatment of cardiac neurosis. Cardiovasc Drugs Ther 1992;6:249-253
47. Scharbach H: [A double blind trial: Oxprenolol/diazepam (author's transl)]. Encephale 1981;7:51-58
48. Schweizer R, Roth WT, Elbert T: Effect of two beta-blockers on stress during mental arithmetic. Psychopharmacology 1991;105:573-577
49. van Vliet IM, den Boer JA, Westenberg HG: Psychopharmacological treatment of social phobia: A double blind placebo controlled study with fluvoxamine. Psychopharmacology (Berl) 1994;115:128-134
50. van der Linden GJ, Stein DJ, van Balkom AJ: The efficacy of the selective serotonin reuptake inhibitors for social anxiety disorder (social phobia): A meta-analysis of randomized controlled trials. Int Clin Psychopharmacol 2000;15(suppl 2):S15-23
51. Stein DJ, Stein MB, Goodwin W, Kumar R, Hunter B: The selective serotonin reuptake inhibitor paroxetine is effective in more generalized and in less generalized social anxiety disorder. Psychopharmacology (Berl) 2001; 158:267-272
52. Asnis GM, Hameedi FA, Goddard AW, Potkin SG, Black D, Jameel M, Desagani K, Woods SW: Fluvoxamine in the treatment of panic disorder: A multi-center, double-blind, placebo-controlled study in outpatients. Psychiatry Res 2001;103:1-14
53. Hjalmarson A, Elmfeldt D, Herlitz J, Holmberg S, Malek I, Nyberg G, Ryden L, Swedberg K, Vedin A, Waagstein F, Waldenstrom A, Waldenstrom J, Wedel H, Wilhelmsen L, Wilhelmsson C: Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet 1981;2:823-827
54. International Study of Infarct Survival Collaborative Group: Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. Lancet 1986;2:57-66
55. Mintz G, Pizzarello R, Klein I: Enhanced left ventricular diastolic function in hyperthyroidism: Noninvasive assessment and response to treatment. J Clin Endocrinol Melab 1991;73:146-150
56. Klein J, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509
57. Australia and New Zealand Heart Failure Research Collaborative Group: Randomised placebo controlled trial of carvedilol in patients with congestive cardiac failure due to ischaemic heart disease. Lancet 1997;349:375-380
58. Metoprolol in Dilated Cardiomyopathy Trial Investigators: 3-Year follow up of patients randomised in the Metoprolol in Dilated Cardiomyopathy Trial. Lancet 1998;351:1180-1181
59. CIBIS-II-Investigators and Committees: The Cardiac Insufficiency Bisoprolol Study II: A randomised trial. Lancet 1999;353:9-13
60. Freitas J, Santos R, Azevedo E, Costa O, Carvalho M, de Freitas AF: Reversible sympathetic vasomotor dysfunction in POTS patients. Rev Port Cardiol 2000;19:1163-1170
61. Freitas J, Santos R, Azevedo E, Costa O, Carvalho M, de Freitas AF: Clinical improvement in patients with orthostatic intolerance after treatment with bisoprolol and fludrocortisone. Clin Auton Res 2000;10:293-299
62. DAVIT II: Effect of verapamil on mortality and major events after acute myocardial infarction (the Danish Verapamil Infarction Trial II-DAVIT II). Am J Cardiol 1990;66:779-785
63. Milner MR, Gelman KM, Phillips RA, Fuster V, Davies TF, Goldman ME: Double-blind crossover trial of diltiazem versus propranolol in the management of thyrotoxic symptoms. Pharmacotherapy 1990;10:100-106
64. Foster MC, Levine PA: Use of verapamil to control an inappropriate chronic sinus tachycardia. Chest 1984;85:697-699
65. Gold RL, Katz RJ, Bren GB, Varghese PJ, Ross AM: Treatment of sinus node reentrant tachycardia with verapamil. Am Heart J 1985;109:1104-1108
66. Yusuf S, Camni A: Sinus tachyarrhythmias and the specific bradycardic agents-a marriage made in heaven. J Cardiovasc Pharmacol Ther 2003;8 (2):89-105
67. Bucchi A, Baruscotti M, DiFrancesco D: Current-dependent block of rabbit sino-atrial node I(f) channels by ivabradine. J Gen Physiol 2002;120:1-13
68. Nicholls DP, Harron DW, Shanks RG: Cardiovascular effects of alinidine and propranolol alone and in combination with hydralazine in normal man. Br J Clin Pharmacol 1983;15:21-29
69. Aubock J, Konzett H, Olbrich E: The effect of alinidine (ST567) on emotionally induced tachycardia in man. Eur J Clin Pharmacol 1982;21:467-471
70. Simoons ML, Tummers J, van Meurs-van Woezik H, van Domburg R: Alinidine, a new agent which lowers heart rate in patients with angina pectoris. Eur Heart J 1982;3:542-545
71. Jacob G, Biagionni I: Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sciences 1999;317:88-101
72. Jacob G, Shannon JR, Black B, Biaggioni I, Mosqueda-Garcia R, Robertson RM, Robertson D: Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997;96:575-580
73. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR: Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 1998;83:339-343
74. Gaffney FA, Lane LB, Pettinger W, Blomqvist CG: Effects of long-term clonidine administration on the hemodynamic and neuroendocrine postural responses of patients with dysautonomia. Chest 1983;83:435-438
75. Grubb B, Karras B: The potential role of serotonin in the pathogenesis of neurocardiogenic syncope and related autonomic disturbances. J Intervent Cardiac Electrophysiol 1998;2:325-332
76. Hoeldtke RD, Horvath GG, Bryner KD: Treatment of orthostatic tachycardia with erythropoietin. Am J Med 1995;99:525-529
77. Shen WK, Low PA, Jahangir A, Munger TM, Friedman PA, Osborn MJ, Stanton MS, Packer DL, Rea RF, Hammill SC: Is sinus node modification appropriate for inappropriate sinus tachycardia with features of postural orthostatic tachycardia syndrome? Pacing Clin Electrophysiol 2001;24:217-230
78. Jayaprakash S, Sparks PB, Vohra J: Inappropriate sinus tachycardia (IST): Management by radiofrequency modification of sinus node. Aust N Z J Med 1997;27:391-397
79. Man KC, Knight B, Tse HF, Pelosi F, Michaud GF, Flemming M, Strickberger SA, Morady F: Radio frequency catheter ablation of inappropriate sinus tachycardia guided by inactivation mapping. J Am Coll Cardiol 2000; 35:451-457
80. Kay GN, Chong F, Epstein AE, Dailey SM, Plumb VJ: Radiofrequency ablation for treatment of primary atrial tachycardias. J Am Coll Cardiol 1993; 21:901-909
81. Lesh MD, Van Hare GF, Epstein LM, Fitzpatrick AP, Scheinman MM, Lee RJ, Kwasman MA, Grogin HR, Griffin JC: Radiofrequency catheter ablation of atrial arrhythmias: Results and mechanisms. Circulation 1994;89: 1074-1089
82. Sandres WJ, Sorrentino R, Greenfield R, Shenasa H, Hamer M, Wharton J: Catheter ablation of sinoatrial node reentrant tachycardia. J Am Coll Cardiol 1994;15:926-934
83. Gomes JA, Mehta D, Langan MN: Sinus node reentrant tachycardia. Pacing Clin Electrophysiol 1995;18:1045-1057
84. Goya M, Iesaka Y, Takahashi A, Mitsuhashi T, Yamane T, Soejima Y, Okamoto Y, Gotoh M, Tanaka K, Nitta J, Nogami A, Amemiya H, Aonuma K, Fujiwara H, Hiroe M, Marumo F: Radiofrequency catheter ablation of sinoatrial node reentrant tachycardia: Electrophysiologic features of ablation sites. Jpn Circ J 1999;63(3):177-183
85. Zipes DP, Dimarco JP, Gillette PC, Jackman WM, Myerburg RJ, Rahimtoola SH, Ritchie JL, Cheitlin MD, Garson A, Gibbons RJ, Lewis RP, O'Rourke RA, Ryan TJ, Schlant RC: Guidelines for clinical intracardiac electrophysiological and catheter ablation procedures. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Clinical Intracardiac Electrophysiologic and Catheter Ablation Procedures), developed in collaboration with the North American Society of Pacing and Electrophysiology. J Am Coll Cardiol 1995;26:555-573